Authors:
Ohe, Y
Yamamoto, S
Suzuki, K
Hojo, F
Kakinuma, R
Matsumoto, T
Ohmatsu, H
Nishiwaki, Y
Citation: Y. Ohe et al., Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer, EUR J CANC, 37(1), 2001, pp. 54-63
Authors:
Ishizaka, M
Ohe, Y
Senbongi, T
Wakabayashi, K
Ishikawa, K
Citation: M. Ishizaka et al., Inflammatory stimuli increase prostaglandin D synthase levels in cerebrospinal fluid of rats, NEUROREPORT, 12(6), 2001, pp. 1161-1165
Authors:
Tatsumi, Y
Arioka, H
Ikeda, S
Fukumoto, H
Miyamoto, K
Fukuoka, K
Ohe, Y
Saijo, N
Nishio, K
Citation: Y. Tatsumi et al., Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6, JPN J CANC, 92(7), 2001, pp. 768-777
Authors:
Kurata, T
Tamura, T
Shinkai, T
Ohe, Y
Kunitoh, H
Kodama, T
Kakinuma, R
Matsumoto, T
Kubota, K
Omatsu, H
Nishiwaki, Y
Saijo, N
Citation: T. Kurata et al., Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer, JPN J CLIN, 31(3), 2001, pp. 93-99
Authors:
Ohe, Y
Niho, S
Kakinuma, R
Kubota, K
Matsumoto, T
Ohmatsu, H
Goto, K
Kunitoh, H
Saijo, N
Nishiwaki, Y
Citation: Y. Ohe et al., Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients, JPN J CLIN, 31(3), 2001, pp. 100-106
Authors:
Akiyama, Y
Ohe, Y
Tamura, T
Sawada, M
Inoue, A
Kusaba, H
Yamamoto, N
Sekine, I
Kunitoh, H
Kodama, T
Saijo, N
Citation: Y. Akiyama et al., A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer, JPN J CLIN, 31(10), 2001, pp. 482-487
Authors:
Tsuchiya, S
Ohe, Y
Sugiura, T
Fuwa, N
Kitamoto, Y
Mori, K
Kobayashi, H
Nakata, K
Sawa, T
Hirai, K
Etoh, T
Saka, H
Saito, A
Fukuda, H
Ishizuka, N
Saijo, N
Citation: S. Tsuchiya et al., Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601), JPN J CLIN, 31(10), 2001, pp. 488-494
Authors:
Kunitoh, H
Akiyama, Y
Kusaba, H
Yamamoto, N
Sekine, I
Ohe, Y
Kubota, K
Tamura, T
Shinkai, T
Kodama, T
Goto, K
Niho, S
Nishiwaki, Y
Saijo, N
Citation: H. Kunitoh et al., A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 259-265
Authors:
Usuda, J
Okunaka, T
Furukawa, K
Tsuchida, T
Kuroiwa, Y
Ohe, Y
Saijo, N
Nishio, K
Konaka, C
Kato, H
Citation: J. Usuda et al., Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis, INT J CANC, 93(4), 2001, pp. 475-480
Citation: Y. Ohe et K. Ichimura, Positive-working photoresists containing tetrahydropyranyl group as an acid-labile polymer for rainbow holograms, J IMAG SC T, 44(1), 2000, pp. 74
Authors:
Sawamura, D
Meng, XM
Ina, S
Kon, A
Tamai, K
Ohe, Y
Hashimoto, I
Citation: D. Sawamura et al., Expression vector with DNA of bovine papilloma virus 1 for keratinocyte gene therapy, J DERMA SCI, 23(2), 2000, pp. 111-116
Authors:
Sekine, I
Matsuda, T
Saisho, T
Watanabe, H
Yamamoto, N
Kunitoh, H
Ohe, Y
Tamura, T
Kodama, T
Saijo, N
Citation: I. Sekine et al., Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatinand thoracic radiotherapy for non-small cell lung cancer: Report of a caseand discussion on dose-limiting toxicity, JPN J CLIN, 30(9), 2000, pp. 401-405
Authors:
Fujishiro, M
Shinkai, T
Fukuda, M
Tamura, T
Ohe, Y
Kunitoh, H
Nishiwaki, Y
Sekine, I
Fukuda, H
Saijo, N
Citation: M. Fujishiro et al., Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408, JPN J CLIN, 30(11), 2000, pp. 487-493
Authors:
Okida, N
Tokumoto, M
Tokumoto, T
Nagahama, Y
Ohe, Y
Miyamoto, K
Ishikawa, K
Citation: N. Okida et al., Cloning of cDNA encoding thimet oligopeptidase from Xenopus oocytes and regulation of the mRNA during oogenesis, ZOOL SCI, 17(4), 2000, pp. 431-436
Authors:
Niho, S
Nishiwaki, Y
Goto, K
Ohmatsu, H
Matsumoto, T
Hojo, F
Ohe, Y
Kakinuma, R
Kodama, T
Citation: S. Niho et al., Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen, LUNG CANC, 27(3), 2000, pp. 159-167
Authors:
Yamamoto, K
Kawai, Y
Hayashi, T
Ohe, Y
Hayashi, H
Toyoda, F
Kawahara, G
Iwata, T
Kikuyama, S
Citation: K. Yamamoto et al., Silefrin, a sodefrin-like pheromone in the abdominal gland of the sword-tailed newt, Cynops ensicauda, FEBS LETTER, 472(2-3), 2000, pp. 267-270
Authors:
Hosomi, Y
Ohe, Y
Mito, K
Uramoto, H
Moriyama, E
Tanaka, K
Kodama, K
Niho, S
Goto, K
Ohmatsu, H
Matsumoto, T
Hojo, F
Kakinuma, R
Nishiwaka, Y
Citation: Y. Hosomi et al., Phase I study of cisplatin and docetaxel plus mitomycin C in patients withmetastatic non-small cell lung cancer, JPN J CLIN, 29(11), 1999, pp. 546-549
Authors:
Fukumoto, H
Tamura, T
Kamiya, Y
Usuda, J
Suzuki, T
Kanzawa, F
Kuh, HJ
Ohe, Y
Saijo, N
Nishio, K
Citation: H. Fukumoto et al., Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01, INV NEW DR, 17(4), 1999, pp. 335-341
Authors:
Fukumoto, H
Nishio, K
Ohta, S
Hanai, N
Fukuoka, K
Ohe, Y
Sugihara, K
Kodama, T
Saijo, N
Citation: H. Fukumoto et al., Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo, INT J CANC, 82(5), 1999, pp. 759-764
Citation: Y. Ohe et al., Application of a photopolymer to a holographic reflector for reflective liquid-crystal displays, APPL OPTICS, 38(32), 1999, pp. 6722-6731